|1.||Fritsche, Thomas R: 2 articles (05/2008 - 03/2008)|
|2.||Sader, Helio S: 2 articles (05/2008 - 03/2008)|
|3.||Rhomberg, Paul R: 2 articles (05/2008 - 03/2008)|
|4.||Jones, Ronald N: 2 articles (05/2008 - 03/2008)|
|5.||Borghi, A: 1 article (11/2010)|
|6.||Virgili, A: 1 article (11/2010)|
|7.||Minghetti, S: 1 article (11/2010)|
|8.||Ricci, M: 1 article (11/2010)|
|9.||Bettoli, V: 1 article (11/2010)|
|10.||Mantovani, L: 1 article (11/2010)|
08/01/2003 - "Micrologix and Fujisawa are developing a gel formulation of MBI-226 for the potential treatment and prevention of various infections caused by both antibiotic-resistant and -sensitive bacteria. "
08/01/2003 - "In September 2000, a phase III trial of MBI-226 for the potential prevention of catheter-related bloodstream infections was initiated."
05/01/2008 - "Omiganan pentahydrochloride is a cidal cationic peptide with a broad antimicrobial spectrum, including yeast, currently in development as a topical agent for the prevention of catheter-associated infections. "
05/01/2008 - "Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections."
03/01/2008 - "Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections."
11/01/2009 - "Omiganan pentahydrochloride is a novel, synthetic, cationic, antimicrobial peptide that is being developed for the prevention of catheter-related infections and the treatment of acne and rosacea. "
11/01/2010 - "New active agents such as topical antimicrobial peptides, inhibitors of ectopeptidase, omiganan pentahydrochloride, antisense oligonucleotides, lauric acid are many original ways to explore for the treatment of acne. "
|4.||Rosacea (Acne Rosacea)
|3.||lauric acid (dodecanoic acid)